Literature DB >> 29118840

Too many pills to swallow: A case of a mixed overdose.

Louise Emily Hopkins1, Jonathan Sunkersing1, Andrew Jacques1.   

Abstract

Propranolol is a highly lipid-soluble beta-receptor antagonist. We describe a case of mixed overdose, including propranolol, amlodipine and olanzapine, resulting in severe resistant hypotension which was successfully treated. A 21-year-old student ingested 6.4 g of propranolol, 280 mg of amlodipine and 560 mg of olanzapine. The patient was brought to the emergency department and exhibited signs of severe systemic toxicity - profound hypotension and circulatory collapse, respiratory depression and coma. The patient had conventional therapy but failed to respond to this and was therefore commenced on IntraLipid infusion, high-dose insulin infusion and inotrope infusion. An endoscopy was performed in intensive care which revealed a large drug beozar - this was removed. We believe that this combination of infusions with early endoscopy could be beneficial in treating similar patients in the future and present the first case of a propranolol drug bezoar.

Entities:  

Keywords:  Drug overdose; beozar; oesophago-gastro-duodenoscopy; propranolol

Year:  2017        PMID: 29118840      PMCID: PMC5665132          DOI: 10.1177/1751143717693860

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  10 in total

1.  Acute beta blocker overdose: factors associated with the development of cardiovascular morbidity.

Authors:  J N Love; J M Howell; T L Litovitz; W Klein-Schwartz
Journal:  J Toxicol Clin Toxicol       Date:  2000

Review 2.  Clinical pharmacology of propranolol.

Authors:  A S Nies; D G Shand
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

3.  A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.

Authors:  J W BLACK; A F CROWTHER; R G SHANKS; L H SMITH; A C DORNHORST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

Review 4.  Characterization of fatal beta blocker ingestion: a review of the American Association of Poison Control Centers data from 1985 to 1995.

Authors:  J N Love; T L Litovitz; J M Howell; C Clancy
Journal:  J Toxicol Clin Toxicol       Date:  1997

Review 5.  Pharmacobezoars described and demystified.

Authors:  Serge-Emile Simpson
Journal:  Clin Toxicol (Phila)       Date:  2011-02       Impact factor: 4.467

6.  Relative toxicity of beta blockers in overdose.

Authors:  D M Reith; A H Dawson; D Epid; I M Whyte; N A Buckley; G P Sayer
Journal:  J Toxicol Clin Toxicol       Date:  1996

7.  A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock.

Authors:  J B Cole; S J Stellpflug; H Ellsworth; C P Anderson; A B Adams; K M Engebretsen; J S Holger
Journal:  Clin Toxicol (Phila)       Date:  2013-03-26       Impact factor: 4.467

8.  A comparison of vasopressin and glucagon in beta-blocker induced toxicity.

Authors:  Joel S Holger; Kristin M Engebretsen; Christopher L Obetz; Tanya L Kleven; Carson R Harris
Journal:  Clin Toxicol (Phila)       Date:  2006       Impact factor: 4.467

Review 9.  Medication bezoars: a literature review and report of a case.

Authors:  J R Taylor; D S Streetman; S S Castle
Journal:  Ann Pharmacother       Date:  1998-09       Impact factor: 3.154

10.  High-dose insulin and intravenous lipid emulsion therapy for cardiogenic shock induced by intentional calcium-channel blocker and Beta-blocker overdose: a case series.

Authors:  Bruce Doepker; William Healy; Eric Cortez; Eric J Adkins
Journal:  J Emerg Med       Date:  2014-02-13       Impact factor: 1.484

  10 in total
  1 in total

Review 1.  Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms.

Authors:  Snežana Đorđević; Nataša Perković Vukčević; Marko Antunović; Vesna Kilibarda; Gordana Vuković Ercegović; Jasmina Jović Stošić; Slavica Vučinić
Journal:  Arh Hig Rada Toksikol       Date:  2022-07-07       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.